A New Test Could Save Arthritis Patients Time, Money, and Pain. But Will It Be Used?
Stories of chronic pain, drug-hopping, and insurance meddling are all too common among patients with rheumatoid arthritis. Precision medicine offers new hope.
New York
181 - 200 of 340 Results
-
-
When a Quick Telehealth Visit Yields Multiple Surprises Beyond a Big Bill
For the patient, it was a quick and inexpensive virtual appointment. Why it cost 10 times what she expected became a mystery.
By Darius Tahir -
‘Financial Ruin Is Baked Into the System’: Readers on the Costs of Long-Term Care
Thousands of people shared their experiences and related to the financial drain on families portrayed in the “Dying Broke” series, a joint project by KFF Health News and The New York Times that examined the costs of long-term care.
-
FTC Chief Gears Up for a Showdown With Private Equity
Lina Khan, chair of the FTC, says a recent lawsuit is meant to chill the consolidation of medical groups that results in higher prices for consumers. But it may be too late to curb price hikes.
By Harris Meyer -
Uncle Sam Wants You … to Help Stop Insurers’ Bogus Medicare Advantage Sales Tactics
The Biden administration wants to crack down on deceptive or misleading Medicare Advantage and drug plan sales tactics. It’s counting on beneficiaries to help catch offenders.
By Susan Jaffe -
How the Thyroid Gland Mystifies Doctors and Patients
This illustrated report has been adapted from a KFF Health News article, “Many Autoimmune Disease Patients Struggle With Diagnosis, Costs, Inattentive Care” by Andy Miller, with artwork by Oona Tempest.
By Oona Zenda and Andy Miller -
Out for Blood? For Routine Lab Work, the Hospital Billed Her $2,400
Convenient as it may be, beware of getting your blood drawn at a hospital. The cost could be much higher than at an independent lab, and your insurance might not cover it all.
-
Adult Children Discuss the Trials of Caring for Their Aging Parents
The financial and emotional toll of providing and paying for long-term care is wreaking havoc on the lives of millions of Americans. Read about how a few families are navigating the challenges, in their own words.
-
States Reconsider Religious Exemptions for Vaccinations in Child Care
Providers and health care advocates warn a proposed rule change in Montana would jeopardize immunity levels in child care centers and communities. Efforts to change vaccination exemption rules are underway in other states, too.
By Matt Volz -
Dads Drive Growth in California’s Paid Family Leave Program
The number of men in the state taking paid family leave to bond with a new child has risen nearly 20% since the start of the pandemic.
-
Storing Guns Away From Home Could Reduce Suicides, but Legal Hurdles Loom
Safe storage maps show gun owners where to put their firearms for safekeeping if they experience a mental health crisis. The idea has support among some gun enthusiasts, but legal obstacles threaten wider adoption.
-
Quick Genetic Test Offers Hope for Sick, Undiagnosed Kids. But Few Insurers Offer to Pay.
A new, rapid genetic test shows promise in increasing diagnoses and improving treatment for some children with rare genetic conditions. Many insurers won’t cover it, but Florida's Medicaid program is among those that see benefits — and, potentially, savings.
-
Rare ‘Flesh-Eating’ Bacterium Spreads North as Oceans Warm
A rise in cases of Vibrio vulnificus and its spread northward have heightened concern about the bacterium, which can cause human tissue to rot and skin to decay. The Centers for Disease Control and Prevention is trying to make more doctors aware of the dangerous pathogen.
-
Police Blame Some Deaths on ‘Excited Delirium.’ ER Docs Consider Pulling the Plug on the Term.
The American College of Emergency Physicians will vote in early October on whether to disavow its 2009 research paper on excited delirium, which has been cited as a cause of death and used as a legal defense by police officers in several high-profile cases.
By Markian Hawryluk and Renuka Rayasam -
Officials Agree: Use Settlement Funds to Curb Youth Addiction. But the ‘How’ Gets Hairy.
Parents, educators, and elected officials agree that investing in school-based prevention efforts could help curb the rising rate of youth drug overdoses. The well-known D.A.R.E. program is one likely choice, but its effectiveness is in question.
-
Save Billions or Stick With Humira? Drug Brokers Steer Americans to the Costly Choice
Thousands of patients with autoimmune diseases who rely on Humira, with a list price of $6,600 a month, could get financial relief from new low-cost rivals. So far, the pharmacy benefit managers that control drug prices in America have not delivered on those savings.
By Arthur Allen -
Naming Suicide in Obits Was Once Taboo. Changing That Can Help Loved Ones Grieve.
Mental health is being talked about more openly than ever, but the word “suicide” has remained largely taboo when describing how someone died. See why that’s slowly changing, what it means for people who grieve those deaths, and how candor can help prevent additional suicides.
-
The CDC Works to Overhaul Lab Operations After Covid Test Flop
In early 2020, U.S. public health labs received covid-19 tests from the Centers for Disease Control and Prevention that were flawed, as a result of poor design and contamination. Now the CDC is overhauling its lab operations, but efforts to be better prepared for future threats won’t be easy, observers say.
-
Hospitals Ask Congress to Delay ACA Medicaid Funding Cuts — For the 14th Time
Congress has until October to avert cuts to a Medicaid program intended to support safety-net hospitals that, in practice, improves the bottom lines of other hospitals, too. Hospital leaders say now is not a good time for the cuts — which lawmakers have so far postponed 13 times.
-
Meet the People Deciding How to Spend $50 Billion in Opioid Settlement Cash
As settlement dollars land at the state level, state councils wield significant power in determining how the windfall gets spent. And, though they will likely include the most knowledgeable voices on addiction, these panels also face concerns about conflicts of interest and other issues.